Volume : 09, Issue : 10, October – 2022

Title:

37.INTRA UTRINE GROWTH RETARDATION AND PRE-ECLAMPSIA: A REVIEW
‬

Authors :

Jawad Ahmad Wasif, Hira Abdur Rehman Qureshi*, Hafa Tufail*, Saira Kainat Awan**, Zahra Ahmad***

Abstract :

Placental examination in pregnancies with complications such as pre-eclampsia (PE) or intrauterine growth restriction (IUGR) can provide insight into specific diagnoses, recurrence risk and chronicity. Placental findings have clinical significance as they can identify the aetiology of the IUGR (as in inborn errors of metabolism) and predict recurrence (as in maternal floor infarcts). Evaluation of obstetric pathology in such pregnancies should be an integral part of clinical care. This review will highlight the placental findings in IUGR and PT.
Keywords: IUGR; Clinical Care; Pre-eclampsia

Cite This Article:

References:

1. Say L, Inoue M, Mills S, Suzuki E. Maternal Mortality in 2005. World Health Organization: Geneva, 2005.
2. Prual A, Bouvier-Colle M, de Bernis L, Breart G. Severe maternal morbidity from direct obstetric causes in West Africa: incidence and case fatality rates. Bull WHO 2000; 78: 593–602.
3. Roberts J, Hubel C. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30: S32–37
4. Burton G, Yung H, Cindrova-Davies T, Charnock-Jones D. Placental endoplasmic reticulum stress and oxidative stress in the pathopysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30: S43–48
5. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis. 2004 Aug 1;175(2):189-202.
6. Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. Journal of clinical pathology. 2008 Dec 1;61(12):1254-60.
7. Cnossen JS, Morris RK, Ter Riet G, Mol BW, Van Der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Cmaj. 2008 Mar 11;178(6):701-11.
8. James JL, Whitley GS, Cartwright JE. Pre‐eclampsia: fitting together the placental, immune and cardiovascular pieces. The Journal of pathology. 2010 Aug;221(4):363-78.
9. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005 Feb 26;365(9461):785-99.
10. Filipek A, Jurewicz E. Preeklampsja – choroba kobiet w ciąży [Preeclampsia – a disease of pregnant women]. Postepy Biochem. 2018 Dec 29;64(4):232-229. Polish. doi: 10.18388/pb.2018_146. PMID: 30656917.
11. Maršál K. Preeclampsia and intrauterine growth restriction: placental disorders still not fully understood. J Perinat Med. 2017 Oct 26;45(7):775-777. doi: 10.1515/jpm-2017-0272. PMID: 28985185.
12. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204:193–201
13. Thilaganathan B. Placental syndromes: getting to the heart of the matter. Ultrasound Obstet Gynecol. 2017;49:7–9.
14. Figueras F, Gratacos E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36:86–98